Trudell Medical Limited expanding into respiratory diagnostics with agreement to acquire Vyaire Medical RDx

Strictly Business, a publication out of Plattsburgh, New York, focuses on construction and development projects in the region, with an eye on continued sustainability and growth in the North Country. In this month’s cover story, Karen Hailson Bouvier interviews Tim Howley (Retired) and Andres Sepcie (Director of Operations) about how the new 35,000 square foot facility is going to set Monaghan Medical up for success and the challenges encountered in building during a pandemic.

Melbourne, Australia – 29 April 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, has signed a heads of terms sales agreement with Monaghan Medical Corporation, a US subsidiary of Trudell Medical Limited, a parent company of a multinational group of leading companies in the medical device and healthcare service sectors, including Trudell Medical International.  Monaghan is a leader in the development and manufacture of innovative, high quality, patient-oriented aerosol drug delivery devices and respiratory management solutions in the United States.  

Trudell Medical Limited has invested in Adherium (Australia) as part of the company’s strategic plan to support organizations with innovative technologies that improve patient outcomes. Adherium is a provider of digital health solutions and a global leader in connected respiratory medical devices, with more than 170,000 sold globally. The company develops, manufactures and supplies a broad range of connected medical devices for respiratory medications for patients, pharmaceutical companies, healthcare providers and contract research organizations.  Trudell subscribed $1,126,000 million of secured debt notes. The funds raised from the issue will be used for working capital purposes.

Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth consecutive year.  The award was presented at the 65th International Respiratory Care Convention and Exhibition in New Orleans, Louisiana.

It is our pleasure to announce that in honour of the late Mitchell Baran, the founder and leader of the Trudell Medical Group of Companies, the City of London has renamed the portion of Third Street that two of the Trudell Companies are located to “Baransway Drive”.